SCHEMBL7050841

SCHEMBL7050841

CCOC(=O)COc1cccc2c1CC[C@](O)(COC(=O)N(c1ccc(F)cc1)c1ccc(F)cc1)C2

nearest known ligand 0.69

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PTGIR P43119 10/20 0.69
PTGDR Q13258 4/20 0.69
PTGER1 P34995 1/20 0.69
PTGER3 P43115 1/20 0.69
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KDM4E B2RXH2 1/20 0.35
NPC1 O15118 1/20 0.35
USP2 O75604 1/20 0.34
KMT2A Q03164 3/20 0.34
POLB P06746 2/20 0.34
MEN1 O00255 1/20 0.34
ATM Q13315 1/20 0.33
ALDH1A1 P00352 1/20 0.33
TSHR P16473 1/20 0.33
HBB P68871 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7047631 0.97 PTGIR (0.74) PTGIRPTGDRPTGER1PTGER3LMNA
SCHEMBL7054735 0.95 PTGIR (0.65) PTGIRPTGDRPTGER1PTGER3
SCHEMBL7776656 0.93 PTGIR (0.80) PTGIRPTGDRPTGER1PTGER3LMNA
SCHEMBL7778514 0.93 PTGIR (0.80) PTGIRPTGDRPTGER1PTGER3LMNA
SCHEMBL7778523 0.93 PTGIR (0.80) PTGIRPTGDRPTGER1PTGER3LMNA
SCHEMBL7051528 0.93 PTGIR (0.62) PTGIRPTGDRPTGER1PTGER3LMNA
SCHEMBL7054777 0.92 PTGIR (0.66) PTGIRPTGDRPTGER1PTGER3
SCHEMBL7748560 0.92 PTGIR (0.66) PTGIRPTGDRPTGER1PTGER3
SCHEMBL7050461 0.90 PTGIR (0.73) PTGIRPTGDRPTGER1PTGER3LMNA
SCHEMBL7050802 0.89 PTGIR (0.87) PTGIRPTGDRPTGER1PTGER3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1042277-B1 NAPHTHALENE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2003-04-23 EP disclosed
US-6303649-B1 FOR THERAPY AND PROPHYLAXIS OF ARTERIAL OBSTRUCTION, CEREBROVASCULAR DISEASE, HEPATIC CIRRHOSIS, ARTERIOSCLEROSIS, ISCHEMIC HEART DISEASE, RESTENOSIS, ISCHEMIC COMPLICATIONS AFTER CORONARY ANGIOPLASTY, HYPERTENSION FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-10-16 US disclosed
EP-1042277-A1 NAPHTHALENE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-10-11 EP disclosed
WO-1999032435-A1 NAPHTHALENE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-07-01 WO disclosed